RIPK1 and hepatocellular carcinoma: The aberration of RIPK1 has been extensively established to be implicated in the pathogenesis of multiple categories of solid cancers by altering cell survival, such as pancreatic, colorectal, hepatocellular cancers, etc. [18–20].